Introduction {#s1}
============

The spindle assembly checkpoint (SAC) safeguards eukaryotic cells against chromosome missegregation by restraining the transition to anaphase in the presence of unattached kinetochores (KTs). Pivotal to this signaling pathway is the Mad1-C-Mad2 heterotetramer that catalyzes the structural conversion of open-Mad2 (O-Mad2) into closed-Mad2 (C-Mad2; [@bib10]). This is the rate-limiting step in the assembly of the mitotic checkpoint complex (MCC), a diffusible tetrameric complex (C-Mad2-Cdc20-BubR1-Bub3) that inhibits anaphase-promoting complex/cyclosome--dependent sister chromatid separation and mitotic exit ([@bib10]; [@bib49]; [@bib14]). The strength of SAC response is dictated by the amount of Mad1-C-Mad2 present at KTs ([@bib6]; [@bib12]; [@bib16]). However, robust SAC signaling also requires Mad1-C-Mad2 at nuclear pore complexes (NPCs) during interphase. Mad1 binds to the nuclear basket nucleoporin Megator/Tpr ([@bib47]; [@bib25]; [@bib11]; [@bib27]; [@bib46]; [@bib43]), which regulates Mad1-C-Mad2 proteostasis to ensure that sufficient levels of this heterotetramer are available before mitosis ([@bib46]). Moreover, it was proposed that Mad1-C-Mad2 at NPCs also converts O-Mad2 into C-Mad2, hence providing a scaffold for MCC assembly in interphase ([@bib43]). This premitotic MCC is thought to operate as a timer to inhibit anaphase-promoting complex/cyclosome during early mitosis until KTs are able to instate efficient SAC activation ([@bib51]; [@bib32]; [@bib31]; [@bib30]; [@bib43]; [@bib23]). Notwithstanding its importance for mitotic fidelity, how the subcellular redistribution of Mad1-C-Mad2 is coordinated with cell cycle progression remains elusive. Particularly, whether and how regulatory events at NPCs affect Mad1-C-Mad2 KT localization has not been established so far. We set out to address these questions in *Drosophila melanogaster*, where the multisequential phosphorylation cascade controlling Mad1 KT localization through the Mps1-Knl1-Bub1 pathway ([@bib29]; [@bib48]; [@bib54]; [@bib38]; [@bib28]; [@bib53]; [@bib34]; [@bib14]; [@bib19]; [@bib40]; [@bib55]; [@bib44]) is inherently absent ([@bib45]; [@bib7]). This reduces KT-associated complexity, hence providing a simpler naturally occurring system to uncover the potential role of KT-extrinsic mechanisms in Mad1-C-Mad2 subcellular distribution throughout the cell cycle and their significance for SAC signaling and genomic integrity in vivo.

Results and discussion {#s2}
======================

Mps1 triggers Mad1 exclusion from NPCs during prophase {#s3}
------------------------------------------------------

To investigate the subcellular redistribution of Mad1 during mitotic entry, we monitored with high-temporal resolution the localization of Mad1 and Megator in *Drosophila* S2 cells ([Fig. 1, A and B](#fig1){ref-type="fig"}). In control cells, Mad1--EGFP signal at the nuclear envelope (NE) begins to fade during early prophase, whereas Megator-EGFP persists until tubulin becomes detectable in the nucleus, an early event of nuclear envelope breakdown (NEB). However, Mps1 depletion significantly delays Mad1-EGFP dissociation from the NE, with no discernible impact on Megator-EGFP dynamics ([Fig. 1, A and B](#fig1){ref-type="fig"}), suggesting that Mad1 relocation from NPCs is triggered before NEB in an Mps1-dependent manner. Consistently, staining with a phospho-specific antibody that recognizes the activating autophosphorylation (T490Ph) of Mps1 T-loop ([@bib18]; [@bib35]) reveals that Mps1 is active at NPCs during prophase ([Fig. 1 C](#fig1){ref-type="fig"}). We then tested whether inducing premature activation of Mps1 in interphase displaces Mad1 from NPCs. As Mps1 is excluded from the nucleus until late G2/early prophase ([@bib56]; [@bib20]), we promoted its nuclear import by fusing it with the SV40 large T-antigen nuclear localization signal (EGFP-Mps1^WT^-NLS). Overexpression of EGFP-Mps1^WT^-NLS elicits nuclear activation of Mps1 ([Fig. S1 A](#figS1){ref-type="fig"}) and decreases Mad1 levels at NPCs of interphase cells ([Fig. 1, D and E](#fig1){ref-type="fig"}), unlike catalytic dead EGFP-Mps1^KD^-NLS or EGFP-Mps1^WT^ ([Fig. 1, D and E](#fig1){ref-type="fig"}), which, although active in the cytoplasm, fails to reach the nucleoplasmic side of NPCs ([Fig. S1 A](#figS1){ref-type="fig"}). Collectively, these results demonstrate that timely control of Mps1 nuclear import and activation triggers Mad1 dissociation from NPCs during early prophase before NEB.

![**Msp1 promotes the dissociation of Mad1 from NPCs during prophase.** **(A and B)** Mitotic progression (A) and quantification (B) of Mad1-EGFP (*n* ≥ 7 cells) or Megator-EGFP (*n* ≥ 6 cells) levels at NE and of mCherry-tubulin levels in the nucleus of control and Mps1-depleted *Drosophila* S2 cells. Time 0 corresponds to NEB. **(C)** Immunofluorescence images of Mps1^T490Ph^ localization in interphase and prophase S2 cells. **(D and E)** Immunofluorescence images (D) and quantifications (E) of Mad1 levels at NE of interphase control S2 cells and interphase S2 cells expressing the indicated transgenes. Graphs in D represent the intensity profiles of EGFP-Mps1, Mad1, and Megator signal along the dotted lines (*n* ≥ 21 cells). In B, data are presented as mean ± SD; in E, data are presented as median with the interquartile range. \*\*, P \< 0.005 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_Fig1){#fig1}

![**Additional information related to**[**Figs. 1**](#fig1){ref-type="fig"}**,**[**2**](#fig2){ref-type="fig"}**, and**[**3**](#fig3){ref-type="fig"}**.** **(A)** Immunofluorescence images of EGFP-Mps1, Mps1^T490Ph^, and Megator localization pattern in interphase control S2 cells and interphase S2 cells expressing EGFP-Mps1^WT^, EGFP-Mps1^WT^-NLS, or EGFP-Mps1^KD^-NLS. To prevent nuclear export, cultured cells were treated with 10 µM Leptomycin B for 3 h. Graphs represent the intensity profiles of GFP-Mps1, Mps1^T490Ph^, and Megator signal along the dotted lines. **(B)** Pull-downs of the indicated recombinant MBP-Megator fragments by bead-immobilized 6xHis-Mad1^1--493^ or 6xHis-BubR1^359--696^ (negative control). Beads (B) and flow-through (FT) were blotted for the indicated proteins. **(C)** Pull-downs of recombinant purified MBP-Megator^1,187--1,655/T2D^, MBP-Megator^1,187--1,655/T3D^, MBP-Megator^1,187--1,655/T4D^ and MBP-Megator^1,187--1,655/T4A^ by bead-immobilized 6xHis-Mad1^1--493^ or 6xHis-BubR1^1--358^ (negative control). B and FT were blotted for the indicated proteins. **(D)** Quantification of MBP-Megator binding to 6xHis-Mad1^1--493^ from pull-downs in C. The graph represents the ratio between the signal intensities of MBP-Megator and 6xHis-Mad1^1--493^. The value obtained for MBP-Megator^1,187--1,655/T4A^ was set to 1. **(E and F)** Representative immunofluorescence images (E) and corresponding quantifications (F) of Mad1 at the NE of interphase S2 cells depleted of endogenous Megator and expressing the indicated Megator-EGFP transgenes. Mad1 fluorescence intensities were determined relative to Nup107 signal (*n* ≥ 24 cells). In F, data are presented as mean ± SD. \*\*\*, P \< 0.001 (Student's *t* test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_FigS1){#figS1}

Mps1-mediated phosphorylation of Megator disrupts its interaction with Mad1 {#s4}
---------------------------------------------------------------------------

Since Megator localizes Mad1 to NPCs ([@bib47]; [@bib25]; [@bib11]; [@bib27]; [@bib46]; [@bib43]), we next sought to examine whether Mps1 activity directly affects this interaction. We found that Megator coimmunoprecipitates with Mad1 in mitotically enriched S2 cell lysates only if Mps1 is depleted ([Fig. 2 A](#fig2){ref-type="fig"}). Moreover, knocking down Mps1 reduced Megator hyperphosphorylation ([Fig. 2 B](#fig2){ref-type="fig"}), which prompted us to test Megator as a direct substrate of Mps1. In vitro kinase assays and mass spectrometry (MS) analysis using three recombinant coiled-coil fragments of Megator, which we confirmed to directly interact with Mad1 N-terminus ([Fig. S1 B](#figS1){ref-type="fig"}; [@bib25]), revealed that GST-Mps1 phosphorylates Megator on T1259, T1302, T1338, and T1390 ([Fig. 2, C and D](#fig2){ref-type="fig"}). Notably, 6xHis-Mad1^1--493^ failed to bind as efficiently to MBP-Megator^1,187--1,655/WT^ previously phosphorylated by GST-Mps1 or to phosphomimetic MBP-Megator^1,187--1,655/T4D^ in which the four phosphorylation sites were converted to aspartates. Since Megator T1259 is adjacent to a conserved threonine in vertebrate orthologues and T1390 is well conserved among eukaryotes, we assessed whether phosphorylation of these two residues was sufficient to impair the interaction with Mad1. Contrasting with MBP-Megator^1,187--1,655/T4D^, the double phosphomimetic for T1259 and T1390 (MBP-Megator^1,187--1,655/T2D^) is efficiently pulled down by 6xHis-Mad1^1--493^ ([Fig. S1, C and D](#figS1){ref-type="fig"}). However, introducing an additional phosphomimetic mutation on T1338 (MBP-Megator^1,187--1,655/T3D^) prevents binding to Mad1 N-terminus ([Fig. S1, C and D](#figS1){ref-type="fig"}). Thus, phosphorylation of Megator on T1259, T1338, and T1390 is sufficient to negatively regulate the association of its central coiled-coil domain with Mad1 N-terminus in vitro. Although T1338 is not conserved, it is replaced by an acidic residue in vertebrate Tpr, indicating that this phospho-regulation may be conserved in vertebrates.

![**Msp1-mediated phosphorylation of Megator disrupts its interaction with Mad1.** **(A and B)** Western blot analysis of Mad1 immunoprecipitates (IP; A) and Megator hyperphosphorylation (B) from lysates of asynchronous and mitotically enriched (+ colchicine) control and Mps1-depleted S2 cells. When indicated, lysates were treated with λ-phosphatase (λPP). **(C)** In vitro kinase assay with recombinant MBP-Megator fragments and GST-Mps1 in the presence of \[γ-^32^P\]ATP. **(D)** Schematic representation of *Drosophila* Megator (ELM resource) and Clustal Omega (EMBL-EBI) local sequence alignment for the indicated Megator/Tpr orthologues. Residues conservation: \*, fully conserved;:, strongly similar properties;., weakly similar properties. Residues phosphorylated by Mps1 (P) were identified by MS analysis after in vitro kinase assay. **(E and F)** Pull-downs of recombinant MBP-Megator^1,187--1,655^ fragments by bead-immobilized 6xHis-Mad1^1--493^ or 6xHis-BubR1^1--358^ (negative control; E) and corresponding quantifications (F) from two independent experiments. B, beads; FT, flow-through. **(G and H)** Immunofluorescence images (G) and schematic representation (H) of EGFP-Megator^1,187--1,655^ clustering by LARIAT in mitotic S2 cells. EGFP-aPKC was used as negative control. **(I and J)** Quantification of Mad1 levels at EGFP-Megator^1,187--1,655^ clusters (*n* ≥ 114 clusters; I) and at KTs (*n* ≥ 64 KTs; J). In F, I, and J, data are presented as mean ± SD. \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 1 µm).](JCB_201906039_Fig2){#fig2}

To examine Mad1--Megator interaction in mitotic cells, we used LARIAT, a CRY2-based optogenetic tool that sequesters target proteins into clusters ([@bib22]; [@bib24]). This can uncover protein--protein interactions through coclustering ([@bib37]). We used CRY2 tagged with an anti-GFP nanobody to cluster WT, phosphodefective (T4A), and phosphomimetic (T4D) versions of EGFP-Megator^1,187--1,655^ ([Fig. 2, G and H](#fig2){ref-type="fig"}). Immunofluorescence analysis revealed limited association of Mad1 with EGFP-Megator^1,187--1,655/WT^ clusters in the cytoplasm of colchicine-treated S2 cells ([Fig. 2, G and I](#fig2){ref-type="fig"}). However, Mad1 coclustering with EGFP-Megator^1,187--1,655/WT^ increased significantly upon depletion of Mps1, and similar levels of Mad1 were observed at EGFP-Megator^1,187--1,655/T4A^ clusters ([Fig. 2, G and I](#fig2){ref-type="fig"}). Importantly, Mad1 failed to associate with EGFP-Megator^1,187--1,655/T4D^ clusters, even after Mps1 knockdown ([Fig. 2, G and I](#fig2){ref-type="fig"}). Collectively, these results demonstrate that Mps1-mediated phosphorylation of Megator on T1259, T1302, T1338, and T1390 prevents it from binding Mad1 during mitosis.

Recruitment of Mad1 to unattached KTs requires its dissociation from Megator {#s5}
----------------------------------------------------------------------------

We then sought to examine the relevance of disengaging Mad1 from Megator in mitosis. In the LARIAT experiment, we observed that Mad1 levels at EGFP-Megator^1,187--1,655^ clusters and at unattached KTs are inversely correlated ([Fig. 2, G--J](#fig2){ref-type="fig"}), which suggested that retaining Mad1 with Megator during mitosis precludes its proper recruitment to KTs. To address this further, we generated stable S2 cell lines transfected with full-length Megator phosphomutants and depleted endogenous Megator. After 24-h induction, all transgenes were expressed at endogenous levels and localized at the NE of interphase cells ([Fig. 3 A](#fig3){ref-type="fig"} and [Fig. 4, A and B](#fig4){ref-type="fig"}). Megator^T4D^-EGFP failed to recruit Mad1 to NPCs as efficiently as Megator^WT^-EGFP ([Fig. 3, A and B](#fig3){ref-type="fig"}; and [Fig. S1, E and F](#figS1){ref-type="fig"}), further confirming that phosphorylation of Megator inhibits its interaction with Mad1. Conversely, Megator^T4A^-EGFP was able to restore Mad1 association with NPCs ([Fig. 3, A and B](#fig3){ref-type="fig"}) but impaired Mad1 accumulation at unattached KTs. Expression of Megator^T4A^-EGFP in colchicine-treated cells resulted in a twofold reduction of KT-associated Mad1 levels compared with Megator^WT^-EGFP cells ([Fig. 3, C and D](#fig3){ref-type="fig"}). As expected, knocking down Mps1 abrogated Mad1 KT localization in Megator^WT^-EGFP cells ([Fig. 3, C and D](#fig3){ref-type="fig"}). However, Megator^T4D^-EGFP cells were still partially competent in recruiting Mad1 to unattached KTs upon depletion of Mps1 ([Fig. 3, C and D](#fig3){ref-type="fig"}). Collectively, these results support that full KT recruitment of Mad1 requires its dissociation from Megator driven by Mps1-mediated phosphorylation.

![**Recruitment of Mad1 to unattached KTs and robust SAC signaling require phosphorylation of Megator by Mps1.** **(A and B)** Immunofluorescence images (A) and quantifications (B) of Mad1 at NE of interphase S2 cells depleted of endogenous Megator and expressing Megator-EGFP transgenes (*n* ≥ 41 cells). **(C and D)** Immunofluorescence images (C) and corresponding quantification (D) of Mad1 at unattached KTs of S2 cells depleted of endogenous Megator and expressing Megator-EGFP transgenes (*n* ≥ 125 KTs). **(E)** Mitotic timings of control and Megator-depleted S2 cells expressing Megator-EGFP transgenes upon addition of taxol (100 nM; *n* ≥ 11 cells) or colchicine (30 µM; *n* ≥ 15 cells). In B, data are presented as median with interquartile range; in D and E, data are presented as mean ± SD. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_Fig3){#fig3}

![**Constitutive impairment of Mad1--Megator interaction reduces the levels of C-Mad2 at KTs.** **(A and B)** Western blots (A) and quantifications (B) of Megator, Mad1, and Mad2 protein levels in lysates from control and Megator-depleted S2 cells expressing Megator-EGFP transgenes. The graph represents the signal intensities of Megator, Mad1, and Mad2 relative to tubulin from at least two independent experiments. The mean value for control parental cells was set to 1. **(C and D)** Immunofluorescence images (C) and quantifications (D) of C-Mad2 at unattached KTs of S2 cells depleted of endogenous Megator and expressing Megator-EGFP transgenes (*n* ≥ 148 KTs). **(E and F)** Immunofluorescence images (E) and quantifications (F) of C-Mad2 levels at unattached KTs of control and Megator-depleted S2 cells (*n* ≥ 224 KTs). **(G)** Mitotic timings of control and Megator-depleted S2 cells expressing Megator-EGFP transgenes under unperturbed (absence of spindle poisons) conditions (*n* ≥ 11 cells). **(H)** Immunoprecipitates (IP) of BubR1 from lysates of control and Megator-depleted S2 cells expressing Megator-EGFP transgenes. When indicated, cells were incubated with colchicine for 18 h. The graph represents the ratio between the signal intensities of Cdc20 and BubR1 present in BubR1 IPs from two independent experiments. The values for control parental cells were set to 1. In B, data are presented as mean ± SEM; in D, F, G, and H, data are presented as mean ± SD. \*, P \< 0.05; \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test in D and Student's *t* test in F and G). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_Fig4){#fig4}

Dissociation of Mad1 from Megator in mitosis is required for functional SAC signaling {#s6}
-------------------------------------------------------------------------------------

To examine the importance of Mps1-mediated phosphorylation of Megator for SAC signaling, we assessed by live-cell imaging the capacity of Megator phosphomutants to arrest in mitosis when incubated with spindle poisons ([Fig. 3 E](#fig3){ref-type="fig"}). In line with SAC proficiency, cells expressing Megator^WT^-EGFP significantly delayed the transition to anaphase in the presence of colchicine (∼640 min) or taxol (∼180 min). In contrast, Megator^T4A^-EGFP cells, although able to halt mitotic progression to some extent in response to unattached KTs (∼360 min in colchicine) or decreased microtubules dynamics (∼87 min in taxol), failed to maintain this arrest for the same amount of time as Megator^WT^-EGFP cells ([Fig. 3 E](#fig3){ref-type="fig"}). This weakened SAC correlates with the observed reduction (∼50%) in Mad1 levels at unattached KTs ([Fig. 3, C and D](#fig3){ref-type="fig"}). Thus, we reason that phosphorylation of Megator by Mps1 is required to provide the KT with a sufficient amount of Mad1 that ensures a robust SAC response.

Constitutive phosphorylation of Megator reduces C-Mad2 levels at KTs and compromises SAC strength {#s7}
-------------------------------------------------------------------------------------------------

Despite being fully competent in recruiting Mad1 to unattached KTs ([Fig. 3, C and D](#fig3){ref-type="fig"}), cells expressing Megator^T4D^-EGFP also fail to arrest in mitosis in response to colchicine as efficiently as Megator^WT^-EGFP cells ([Fig. 3 E](#fig3){ref-type="fig"}). Hence, constitutive phosphorylation of Megator is equally deleterious for SAC. Mad1 and Mad2 form a highly stable complex in vitro ([@bib50]; [@bib10]; [@bib52]) and interact with each other throughout the cell cycle ([@bib4]; [@bib5]; [@bib15]; [@bib46]). In human cells, Tpr has been proposed to protect Mad1-C-Mad2 from proteolytic degradation ([@bib46]). We confirmed in *Drosophila* cells a significant reduction in the total levels of Mad1 and Mad2 following Megator depletion ([Fig. 4, A and B](#fig4){ref-type="fig"}; and [Fig. S2 D](#figS2){ref-type="fig"}). However, the levels of both proteins are partially rescued to a similar extent regardless of the Megator-EGFP transgene expressed ([Fig. 4, A and B](#fig4){ref-type="fig"}), which argues against altered proteostasis as the main cause underlying the weakened SAC function in Megator^T4D^-EGFP cells.

![**KT-extrinsic activity of Mps1 contributes to Mad1 KT recruitment.** **(A and B)** Immunofluorescence images (A) and quantifications (B) of Mad1 and Mps1 levels at unattached KTs of neuroblasts from *w^1118^* or homozygous *mps1^G4422^* flies. When indicated, EGFP-Mps1-C^term^ or EGFP-Mps1-WT transgenes were expressed under control of *Mps1* native promoter in a homozygous *mps1^G4422^* background. To generate unattached KTs, neuroblasts were incubated with colchicine (50 µM) for 90 min. Mad1 and Mps1 fluorescence intensities were determined relative to Spc105 signal (*n* ≥ 106 KTs). **(C)** Western blot analysis of endogenous Mps1, EGFP-Mps1-WT, and EGFP-Mps1-C^term^ levels in total lysates of third instar larval brains from A. **(D)** Western blot analysis of Mps1, Megator, and Mad1 relative levels in control S2 cells and in cells depleted of the indicated proteins. Cells were incubated with MG123 (20 µM) for 1 h and with colchicine (30 µM) for 2 h. Asterisk denotes bands resulting from unspecific anti-GFP blotting. **(E and F)** Immunofluorescence images (E) and quantifications (F) of Mad1 and Mps1 levels at unattached KTs of control S2 cells and cells depleted of the indicated proteins. Cells were incubated with MG123 (20 µM) for 3 h and with colchicine (30 µM) for 2 h. Mad1 and Mps1 fluorescence intensities were determined relative to CID signal (*n* ≥ 109 KT for Mad1, *n* ≥ 139 KTs for Mps1). **(G)** Mitotic index quantification based on H3^Ser10Ph^ staining of control S2 cells and cells depleted of the indicated proteins. Cells were incubated with colchicine (30 µM) for the indicated time periods. In B, F, and G, data are presented as mean ± SD. \*, P \< 0.05; \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_FigS2){#figS2}

Using an antibody specific for C-Mad2 ([@bib15]) we detected a significant decrease in C-Mad2 levels at unattached KTs of cells expressing Megator^T4D^-EGFP compared with Megator^WT^-EGFP cells ([Fig. 4, C--F](#fig4){ref-type="fig"}). We envisage that, in vivo*,* Megator/Tpr may function as a scaffold to assemble the Mad1-C-Mad2 complex before its targeting to KTs. Hence, while Mad1 dissociation from Megator is required for efficient KT recruitment of Mad1-C-Mad2, prematurely abrogating Mad1-Megator interaction during interphase is detrimental for SAC, as it may compromise the assembly of Mad1-C-Mad2 ([@bib46]). Accordingly, a weakened SAC function is also observed in parental S2 cells and human cultured cells depleted of Megator ([Figs. 3 E](#fig3){ref-type="fig"} and [Fig. S2 G](#figS2){ref-type="fig"}) or Tpr ([@bib46]; [@bib43]), respectively. Furthermore, disrupting Mad1 localization from NPCs may also affect the formation of premitotic MCC ([@bib43]), which is required for full SAC activity and to define the minimum length of time in mitosis in the absence of KT--microtubule attachment problems ([@bib43]). Cells expressing Megator^T4D^-EGFP, however, fail to exit faster from mitosis ([Fig. 4 G](#fig4){ref-type="fig"}), contrasting with Megator-depleted S2 cells ([Fig. 4 G](#fig4){ref-type="fig"}) or human cells in which Mad1--Tpr interaction is impaired ([@bib43]). This prompted us to examine the assembly of interphase MCC in asynchronous cultured S2 cells (∼97% interphase cells). While depletion of Megator reduced the levels of BubR1-bound Cdc20 in interphase lysates, expression of Megator^T4D^-EGFP restored premitotic MCC levels to a similar extent as Megator^WT^-EGFP ([Fig. 4 H](#fig4){ref-type="fig"}). These data suggest that the residual pool of Mad1 still present at NPCs when Megator^T4D^-EGFP is expressed ([Fig. S1, E and F](#figS1){ref-type="fig"}) may generate sufficient MCC during interphase to support normal mitotic timing in the absence of spindle poisons. These cells, however, fail to exhibit a robust KT-dependent SAC response ([Fig. 3 E](#fig3){ref-type="fig"}) due to limited association of C-Mad2 with KT-bound Mad1 ([Fig. 4, C and D](#fig4){ref-type="fig"}).

Mad1 release from NPCs rescues chromosome missegregation and aneuploidy in *mps1*-null neuroblasts {#s8}
--------------------------------------------------------------------------------------------------

The results so far demonstrate that Mps1 abolishes Mad1 interaction with Megator to promote Mad1 KT recruitment. We next assessed whether this mechanism occurs in vivo and whether it is relevant for genomic stability. We used *mps1*-null mutant flies (*mps1^G442^*^2^; [@bib3]; [@bib7]) to express a truncated version of Mps1 that lacks the N-terminus domain (gEGFP-Mps1-C^term^) required for KT targeting ([@bib2]) and examined its capacity to recruit Mad1 to unattached KTs. Notably, neuroblasts expressing the gEGFP-Mps1-C^term^ transgene under control of *mps1* promoter were still able to partially recruit Mad1 to unattached KTs (50% of the levels detected in control *w^1118^* flies; [Fig. S2, A--C](#figS2){ref-type="fig"}), confirming in vivo a KT-extrinsic role for Mps1 in promoting Mad1 KT localization. Furthermore, RNAi-mediated repression of Megator restored Mad1 KT recruitment in a *mps1^G442^*^2^ genetic background in vivo ([Fig. 5, A and B](#fig5){ref-type="fig"}). Importantly, this concomitantly rescued the elevated rates of aneuploidy caused by loss of Mps1 (∼70% mitotic figures with aneuploid karyotypes in *mps1^G442^*^2^ versus ∼30% in *mps1^G442^*^2^ + Megator RNAi; [Fig. 5 A](#fig5){ref-type="fig"}). To test whether this recovery in genomic stability was due to improved fidelity of chromosome segregation, we monitored the mitotic progression of larval neuroblasts by live imaging ([Fig. 5, C--E](#fig5){ref-type="fig"}; and [Videos 1](#video1){ref-type="fig"}, [2](#video2){ref-type="fig"}, [3](#video3){ref-type="fig"}, and [4](#video4){ref-type="fig"}). Interestingly, although *UAS-MegatorRNAi* and *mps1^G442^*^2^ neuroblasts have similarly decreased mitotic timings (∼5 min vs. ∼7.3 min in *w^1118^* controls), the frequency of anaphases with lagging chromosomes is dramatically higher in *mps1^G442^*^2^ mutants ([Fig. 5, C--E](#fig5){ref-type="fig"}). Importantly, depletion of Megator significantly restores the accuracy of segregation in *mps1^G442^*^2^ neuroblasts, although failing to extend the time from NEB to anaphase onset ([Fig. 5, C--E](#fig5){ref-type="fig"}). A similar defect in SAC function was observed in cultured S2 cells codepleted of Mps1 and Megator: although proficient in Mad1 KT recruitment ([Fig. S2, E and F](#figS2){ref-type="fig"}), these cells failed to arrest in mitosis when challenged with colchicine ([Fig. S2 G](#figS2){ref-type="fig"}). This was expected due to compromised Mps1-mediated phosphorylation of Mad1, which is required to promote Cdc20-C-Mad2 interaction and consequently MCC assembly ([@bib14]; [@bib19]). Hence, in *Drosophila* neuroblasts undergoing unperturbed mitosis, KT-associated Mad1 is able to efficiently safeguard anaphase fidelity and chromosomal euploidy independently of its SAC function. This is in line with previous studies reporting a role for Mad1 in preventing merotely independently of its interaction with Mad2 and SAC signaling ([@bib13]; [@bib1]). Collectively, these results strongly support that Mps1-mediated dissociation of Mad1 from Megator is a critical event for efficient KT localization of Mad1, the fidelity of chromosome segregation, and consequently, genome stability in vivo.

![**Depletion of Megator restores Mad1 KT recruitment and mitotic fidelity in *Drosophila mps1*-null neuroblasts.** **(A and B)** Immunofluorescence images with ploidy histograms (A) and quantifications (B) of Mad1 levels at unattached KTs of *w^1118^*, *InscGal4\>UAS-MegatorRNAi*, homozygous *mps1^G4422^*, or homozygous *mps1^G4422^*;*InscGal4\>UAS-MegatorRNAi* neuroblasts treated with colchicine (50 µM) for 90 min (*n* ≥ 91 KTs). **(C--E)** Mitotic progression (C), mitotic timing (D), and percentage of anaphases with lagging chromosomes (E) in neuroblasts with indicated genotypes coexpressing the microtubule-associated protein Jupiter-GFP and H2B-mRFP. The mitotic timing corresponds to the time from NEB to anaphase onset (AO; *n* ≥ 14 neuroblasts from at least two independent experiments). The arrowhead in C points to a lagging chromosome. **(F)** Model for the control of Mad1 subcellular redistribution during the G2/M transition. In interphase, inactive Mps1 (unphosphorylated T-loop) is in the cytoplasm and Mad1-C-Mad2 is docked to Megator at the nucleoplasmic side of NPCs, where it catalyzes the assembly of premitotic MCC. During prophase, active Mps1 (phosphorylated T-loop) becomes detectable in the nucleus and is now able to phosphorylate Megator, disrupting the interaction with Mad1. This ensures timely release of Mad1-C-Mad2 from NPCs, which enables Mad1-C-Mad2 to accumulate at prometaphase KTs and instate robust SAC signaling. In A--C and E, data are presented as mean ± SD. \*, P \< 0.05; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_Fig5){#fig5}
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**Mitotic progression of *w^1118^* neuroblasts.** Related to [Fig. 5, C--E](#fig5){ref-type="fig"}. Mitotic progression of *w^1118^* neuroblasts coexpressing Jupiter-GFP (green) and H2B-mRFP (red) was monitored by spinning disk confocal microscopy. H2B-mRFP signal is shown on the right. Frames were acquired every 20 s. NEB corresponds to time 0.0. Time is shown in minutes.
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**Mitotic progression of ***InscGal4\>UAS-MegatorRNAi***neuroblasts.** Related to [Fig. 5, C--E](#fig5){ref-type="fig"}. Mitotic progression of *^*InscGal4\>UAS-MegatorRNAi*^* mutant neuroblasts coexpressing Jupiter-GFP (green) and H2B-mRFP (red) was monitored by spinning disk confocal microscopy. H2B-mRFP signal is shown on the right. Frames were acquired every 20 s. NEB corresponds to time 0.0. Time is shown in minutes.
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**Mitotic progression of*mps1^G4422^*neuroblasts.** Related to [Fig. 5, C--E](#fig5){ref-type="fig"}. Mitotic progression of homozygous *mps1^G4422^* neuroblasts coexpressing Jupiter-GFP (green) and H2B-mRFP (red) was monitored by spinning disk confocal microscopy. H2B-mRFP signal alone is shown on the right. Frames were acquired every 20 s. NEB corresponds to time 0.0. Time is shown in minutes.
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###### 

**Mitotic progression of *mps1^G4422^*; *InscGal4\>UAS-MegatorRNAi* neuroblasts.** Related to [Fig. 5, C--E](#fig5){ref-type="fig"}. Mitotic progression of homozygous *mps1^G4422^*; *InscGal4\>UAS-MegatorRNAi* neuroblasts coexpressing Jupiter-GFP (green) and H2B-mRFP (red) was monitored by spinning disk confocal microscopy. H2B-mRFP signal is show on the right. Frames were acquired every 20 s. NEB corresponds to time 0.0. Time is shown in minutes.

Depletion of Tpr partially restores Mad1 KT recruitment in human cells lacking Mps1 activity {#s9}
--------------------------------------------------------------------------------------------

Since two of the identified Mps1 sites on Megator (T1259 and T1390) are conserved in vertebrate Tpr, and a third one (T1338) occurs as glutamic acid, we tested whether an analogous mechanism operates in human cells. Reversine-mediated inactivation of Mps1 severely compromised Mad1 KT accumulation in HeLa and RPE cells treated with nocodazole ([Fig. S3, A--D](#figS3){ref-type="fig"}). However, siRNA-mediated depletion of Tpr was able to partially rescue the recruitment of Mad1 to unattached KTs of both cell lines in the presence of reversine ([Fig. S3, A--D](#figS3){ref-type="fig"}). These results, and the recent observation that Mad1 remains associated with Tpr during early mitosis in reversine-treated RPE cells ([@bib17]), strongly support that this KT-extrinsic mechanism orchestrated by Mps1 is evolutionarily conserved in vertebrates, where it likely coordinates with Cyclin B1--CDK1 ([@bib17]) the release of Mad1 from NPCs to enable its proper KT localization.

![**Depletion of Tpr partially restores Mad1 KT recruitment in human cells lacking Mps1 activity.** Immunofluorescence images (A and B) and quantifications (C and D) of Mad1 levels at unattached KTs of HeLa (A and C) or RPE1 cultured cells (B and D) in the indicated conditions. Cells were incubated with nocodazole (3.3 µM) and MG132 (1 µM) for 3 h (HeLa) or 6 h (RPE). When indicated, cells were treated with Tpr siRNA (50 nM) for 48 h and/or reversine (1 µM) for 1 h before nocodazole + MG132 incubation. Mad1 fluorescence intensities were determined relative to CenpC (*n* ≥ 4,081 KTs for HeLa cells, *n* ≥ 519 KTs for RPE cells). Data are presented as mean ± SD. \*\*\*\*, P \< 0.0001 (Kruskal--Wallis, Dunn's multiple comparison test). Scale bars, 5 µm (inset, 0.5 µm).](JCB_201906039_FigS3){#figS3}

Our biochemical, cellular, and in vivo data concur to demonstrate that Mps1 activity at NPCs early in prophase sets the stage to enable appropriate recruitment of Mad1 to unattached/prometaphase KTs ([Fig. 5 F](#fig5){ref-type="fig"}). Phosphorylation of Megator by Mps1 abrogates Megator interaction with Mad1, which is essential for KT localization of Mad1-C-Mad2 at levels required to sustain robust SAC signaling and accurate chromosome segregation. During interphase, nuclear exclusion and reduced activity of Mps1 prevent the premature dissociation of Mad1 from NPCs. This is most likely important to facilitate Mad1-C-Mad2 interaction and MCC assembly before mitotic entry and KT maturation ([@bib43]; [@bib23]). Together, these observations establish that a key function of non-KT Mps1 is to coordinate Mad1 subcellular localization with cell cycle progression, so that both nuclear pores in interphase and KTs in mitosis generate anaphase inhibitors that preserve genomic stability.

Materials and methods {#s10}
=====================

S2 cell cultures, RNAi-mediated depletion, and drug treatments {#s11}
--------------------------------------------------------------

The *Drosophila* S2-DGRC cell line (\#stock6) was acquired from the Drosophila Genomics Resource Center, Indiana University, and was not independently authenticated. The cell lines routinely tested negative for mycoplasma contamination. Cell cultures, RNAi synthesis, and RNAi treatment were performed as previously described ([@bib7]). S2 cells were incubated with 30 µg of Mps1 RNAi or Megator UTRs RNAi for 120 h in 1.5 ml of Schneider's insect medium (Sigma-Aldrich).

The PCR product used as template to produce Mps1 RNAi was amplified with the set of primers Mps1F (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGT​CTT​CCA​AAC​ACC​TAT​GAC​CG-3′) and Mps1R (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGC​GTT​TAG​ATA​TCC​CTG​CAC​CA-3′). The PCR product used as template to produce Megator 5′ UTR RNAi was amplified with Mtor5′\_F (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGA​TTT​TTT​CGC​GTC​CCT​AAA​G-3′) and Mtor5′\_R (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGT​TGA​TCC​TTG​TCA​AGC​AGC-3′). The PCR product used as template to produce Megator 3′ UTR RNAi was amplified with Mtor3′\_F (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGG​GCG​AGG​AGT​TCG​GCG​GAC​C-3′) and Mtor3′\_R (5′-TAA​TAC​GAC​TCA​CTA​TAG​GGA​TCG​ACA​AAA​TTA​CAC​ATA​T-3′). At selected time points, cells were collected and processed for immunofluorescence, time-lapse microscopy, immunoblotting, or immunoprecipitation. When required, cells were subjected to several drug treatments before being collected and processed for the desired analysis. To promote microtubule depolymerization, cells were incubated with 30 µM colchicine (Sigma-Aldrich). To decrease microtubule dynamics, cells were incubated with 100 nM taxol (Sigma-Aldrich). When required, 20 µM MG132 (Calbiochem) was added to inhibit the proteasome. For [Fig. 2 (A, B, G, I, and J)](#fig2){ref-type="fig"}, cells were incubated with colchicine for 10 h, and MG132 was added 4 h before cell processing. For [Fig. 3 (C and D)](#fig3){ref-type="fig"} and [Fig. 4 (C--F)](#fig4){ref-type="fig"}, cells were incubated with colchicine and MG132 for 30 min before fixation. For [Fig. 3 E](#fig3){ref-type="fig"}, cells were added immediately before live-imaging acquisition. For [Fig. 4 (A, B, and H)](#fig4){ref-type="fig"}, when indicated, cells were treated with colchicine for 18 h before lysis. For experiments in [Fig. 1 (D and E)](#fig1){ref-type="fig"} and [Fig. S1 A](#figS1){ref-type="fig"}, cells were incubated with 10 µM Leptomycin B (Sigma-Aldrich) for 3 h to block Crm1-mediated nuclear export.

Constructs and S2 cell transfection {#s12}
-----------------------------------

Recombinant plasmids pHWG\[blast\]-Megator^WT^, pHWG\[blast\]-Megator^T4A^, pHWG\[blast\]-Megator^T4D^, pHGW\[blast\]-Megator^1,187--1,655/WT^, pHGW\[blast\]-Megator^1,187--1,655/T4A^, pHGW\[blast\]-Megator^1,187--1,655/T4D^, and pHGW\[blast\]-Mps1^WT^ were generated using the Gateway Cloning System (Invitrogen). Megator, Megator^1,187--1,655^, or Mps1 cDNAs were amplified by PCR and inserted into modified versions of pENTR-entry vector through FastCloning ([@bib26]). To generate pENTR-Megator^1,187--1,655/T4A^ and pENTR-Megator^1,187--1,655/T4D^, codons corresponding to T1259, T1302, T1338, and T1390 of pENTR-Megator^1,187--1,655^ were converted to codons for either alanine (A) or aspartate (D), respectively, by several cycles of site-directed mutagenesis with primers harboring the desired mutations. To generate pENTR-Megator^T4A^ and pENTR-Megator^T4D^, the fragment corresponding to aa 1,187--1,655 on pENTR-Megator^WT^ was replaced by Megator^1,187--1,655/T4A^ or Megator^1,187--1,655/T4D^ PCR products, respectively, through FastCloning ([@bib26]). PCRs were performed using Phusion polymerase (New England Biolabs). PCR products were digested with DpnI restriction enzyme (New England Biolabs), used to transform competent bacteria and selected for positives. Subsequently, pENTR-Megator^1,187--1,655^ constructs and pENTR-Mps1 were recombined with pHGW\[blast\] (blasticidin^R^; N-terminal EGFP tag) and pENTR-Megator constructs with pHWG (blasticidin^R^; C-terminal EGFP tag) using Gateway LR Clonase II (Invitrogen), according to the manufacturer's instructions. pHGW-Mps1^WT^-NLS was produced by PCR amplification of pHGW-Mps1^WT^ with primers harboring SV40 large T-antigen NLS sequence. pHGW-Mps1^KD^-NLS was produced by site-directed mutagenesis of pHGW-Mps1^WT^-NLS with primers harboring the mutation to convert D478 to A478. PCRs were performed with Phusion polymerase, followed by digestion with DpnI restriction enzyme (New England Biolabs). The constructs H2B-mCherry, H2B-GFP, mCherry--α-tubulin, Mad1-EGFP, pHW-CIB-MP-HRW-CRY2-V~H~H, and pHGW-aPKC have been previously described ([@bib7]; [@bib35]; [@bib37]). Plasmids were transfected into S2 cells using Effectene Transfection Reagent (Qiagen), according to the manufacturer's instructions. Transiently expressing cells were harvested 4--5 d after transfections. Stable cell lines were obtained by selection in medium with 25 µg/ml blasticidin. To induce expression of pHW-CIB-MP-HRW-CRY2-V~H~H, pHGW\[blast\], or pHWG\[blast\] constructs, cells were incubated for 30 min at 37°C 24 h before processing. Cells transfected with pHW-CIB-MP-HRW-CRY2-V~H~H were maintained in the dark until processing.

Live-cell imaging {#s13}
-----------------

Live analysis of mitosis was performed in S2 cell lines and neuroblasts expressing the indicated constructs. S2 cells were plated on glass-bottom dishes (MatTek) coated with Concanavalin A (0.25 mg/ml; Sigma-Aldrich). Third-instar larvae brains were dissected in PBS and mounted in PBS between coverslips of different sizes. The preparation was squashed and sealed with Halocarbon oil 700 (Sigma-Aldrich). 4D datasets were collected at 25°C with a spinning disc confocal system (Revolution; Andor) equipped with an electron multiplying charge-coupled device camera (iXonEM+; Andor) and a CSU-22 unit (Yokogawa) based on an inverted microscope (IX81; Olympus). Two laser lines (488 and 561 nm) were used for near-simultaneous excitation of EGFP and mCherry or RFP. The system was driven by iQ software (Andor). Time-lapse imaging of z stacks with 0.8-µm steps for S2 cells and 0.5-µm steps for neuroblasts were collected, and image sequence analysis, video assembly, and fluorescence intensity quantification were performed using ImageJ (National Institutes of Health). Quantification of Mad1-EGFP and Megator-EGFP levels at the NE and mCherry-tubulin at the nucleus was performed on single Z stacks from images acquired with fixed exposure settings. Mad1-EGFP and Megator-EGFP intensities at the NE were determined for each time point (*t*), using the following formula:$$\frac{\left( {Bi - bm \times Ba} \right) - \left( {Si - bm \times Sa} \right)}{\left( {Ba - Sa} \right)} \times \frac{Cit}{Cit0},$$where *Bi* is the integrated density of a region of interest (ROI) harboring the nucleus (including outer nuclear membrane); *Ba* is the area of the ROI harboring the nucleus; *Si* is the integrated density of an ROI encompassing the nucleoplasm; *Sa* is the area of the ROI harboring the nucleoplasm; *bm* is the mean intensity of an ROI outside the cell (background); *Cit* is the integrated density of an ROI harboring the cell at time *t*; and *Cit*0 is the integrated density of an ROI harboring the cell on the first frame. mCherry-tubulin intensities in the nucleus were determined for each time point (*t*), using the following formula:$$\left( {Nm - bm} \right) \times \frac{Cit}{Cit0},$$where *Nm* is the mean intensity of an ROI inside the nucleus; *bm* is the mean intensity of the background; *Cit* is the integrated density of an ROI harboring the cell at time *t*; and *Cit*0 is the integrated density of an ROI harboring the cell on the first frame. The changes in fluorescence intensity over time were plotted as normalized signal relative to the mean signal measured before NEB.

Immunofluorescence analysis {#s14}
---------------------------

For immunofluorescence analysis of S2 cells, 10^5^ cells were centrifuged onto slides for 5 min at 1,500 rpm (Cytospin 2, Shandon). For LARIAT experiments, cells were irradiated with blue light for 30 min before centrifugation to trigger the formation of protein clusters through blue light--mediated heterodimerization between the cryptochrome CRY2 fused to an anti-GFP nanobody and a multimeric version of the cryptochrome-interacting basic helix-loop-helix 1. Afterward, cells were fixed in 4% PFA in PBS for 12 min and further extracted for 8 min with 0.1% Triton X-100 in PBS. Alternatively, cells were simultaneously fixed and extracted in 3.7% formaldehyde (Sigma-Aldrich) and 0.5% Triton X-100 in PBS for 10 min followed by three washing steps of 5 min with PBST (PBS with 0.05% Tween20). For immunofluorescence analysis of *Drosophila* neuroblasts, third-instar larval brains were dissected in PBS and incubated with 50 µM colchicine for 90 min. Afterward, the brains were fixed in 1.8% formaldehyde (Sigma-Aldrich) and 45% glacial acetic acid for 5 min, squashed between slide and coverslip, and immersed in liquid nitrogen. Subsequently, coverslips were removed, and the slides were incubated in cold ethanol for 10 min and washed in PBS with 0.1% Triton X-100. Immunostaining was performed as previously described ([@bib35]). Images were collected in a Zeiss Axio Imager microscope (Carl Zeiss) or a Leica TCS II scanning confocal microscope (Leica Microsystems). For immunofluorescence quantification, the mean pixel intensity was obtained from raw images acquired with fixed exposure acquisition settings. Fluorescence intensities at the NE were obtained from single Z stack projections. The NE was defined based on Megator or Megator-EGFP staining, by subtracting an ROI containing the nucleoplasm from an ROI harboring the entire nucleus (outer membrane) after subtraction of background intensities estimated from regions outside the cell. Mad1 fluorescence intensities were determined relative to Nup107, Megator, or Megator-EGFP. Fluorescence intensities of LARIAT-mediated clustered proteins and KT proteins were obtained from maximum projected images. For Mad1 and EGFP-Megator^1,187--1,655^, the fluorescence intensities were quantified for individual clusters selected manually by mRFP-Cry2 staining. After subtraction of background intensities estimated from regions inside the cell with no clusters, the intensity of Mad1 was determined relative to Megator-EGFP signal. For KT proteins, the fluorescence intensity was quantified for individual KTs selected manually by Mad1, CID, or Spc105 staining. The size of the ROI was predefined so that each single KT could fit into it. After subtraction of background intensities, estimated from regions outside the cell, the intensity of the proteins was determined relative to cytoplasmic Mad1, CID, or Spc105.

S2 cell lysates, immunoprecipitation, and Western blotting {#s15}
----------------------------------------------------------

For *Drosophila* brain lysates, at least 10 third-instar larvae brains were dissected in PBS, transferred to Laemmli buffer (4% SDS, 10% β-mercaptoethanol, 0.125 M Tris-HCl, 20% glycerol, and 0.004% bromophenol blue), and boiled at 95°C for 5 min. S2 cell lysates for immunoprecipitation and Western blot analysis were obtained from nontransfected S2 cells or S2 cells expressing Megator-EGFP transgenes treated with colchicine and MG132 when indicated. For Western blot of total S2 cell lysates, 10^6^ cells were harvested through centrifugation at 5,000 rpm for 10 min. The resulting pellet was resuspended in Laemmli sample buffer and boiled at 95°C for 5 min.

For immunoprecipitation assays, cells were harvested through centrifugation at 5,000 rpm for 10 min at 4°C and washed with 2 ml PBS supplemented with 1× protease inhibitor cocktail (Roche). The cell pellet was resuspended in lysis buffer (150 mM KCl, 75 mM Hepes, pH 7.5, 1.5 mM EGTA, 1.5 mM MgCl~2~, 15% glycerol, 0.1% NP-40, 1× protease inhibitor cocktail \[Roche\], and 1× phosphatase inhibitor cocktail 3 \[Sigma-Aldrich\]) before freezing disruption in liquid nitrogen. Cell lysates were then clarified through centrifugation at 10,000 rpm for 10 min at 4°C and concentration determined by measuring absorbance at 280 nm in the Nanodrop 1000 (Thermo Fisher Scientific). Lysates containing 800 or 1,000 µg of protein in a total volume of 400 µl lysis buffer were precleared by incubation with 15 or 20 µl Protein A magnetic beads (New England Biolabs), respectively, for 1 h at 4°C under agitation. Precleared extracts were incubated with rabbit anti-Mad1 (1:100) or anti-BubR1 (1:100) overnight, at 4°C under agitation. Afterward, the mixture was incubated with 40 or 50 µl of Protein A magnetic beads for 90 min, at 4°C with agitation. Magnetic beads were collected and washed four times with 500 µl of lysis buffer. Magnetic beads were resuspended in Laemmli sample buffer and boiled at 95°C for 5 min. To confirm protein hyperphosphorylation status, 50 µg of mitotic cell lysates were treated with 400 U of λ-phosphatase (New England Biolabs) at 30°C for 1 h in a total volume of 50 µl PMP phosphatase buffer (50 mM Hepes, pH 7.5, 100 mM NaCl, 2 mM DTT, 0.01% Brij 35, and 1 mM MnCl~2~; New England Biolabs).

Samples were resolved by SDS-PAGE and transferred to a nitrocellulose membrane, using the iBlot Dry Blotting System (Invitrogen) according to the manufacturer's instructions. Transferred proteins were confirmed by Ponceau staining (0.25% Ponceau S in 40% methanol and 15% acetic acid). The membrane was blocked for 1 h at room temperature with 5% powder milk prepared in PBST and subsequently incubated with primary antibodies diluted in blocking solution overnight at 4°C under agitation. Membranes were washed three times for 10 min with PBST and incubated with secondary antibodies (diluted in blocking solution) for 1 h at room temperature with agitation. Secondary antibodies conjugated to HRP (Santa Cruz Biotechnology) or VeriBlot for IP Detection Reagent (ab131366; Abcam) were used according to the manufacturer's instructions. Blots were developed with ECL Chemiluminescent Detection System (Amersham) according to the manufacturer's protocol and detected on x-ray film (Fuji Medical). When required, proteins were resolved in 4--20% Mini-Protean TGX Precast Gel (Bio-Rad) and transferred to nitrocellulose membrane overnight in 48 mM Tris, 39 mM glycine, 0.037% SDS, and 20% methanol, pH 8.3, at 20 V and 4°C.

Production and purification of recombinant proteins {#s16}
---------------------------------------------------

To generate 6xHis-Mad1^1--493^, 6xHis-BubR1^1--358^, and 6xHis-BubR1^359--696^ constructs for expression in bacteria, PCR products with the corresponding coding sequence were cloned into NdeI/XhoI or SalI/XhoI, sites of pET30a (+) vector (Novagen). TOP10 competent cells were transformed and selected for positives. The recombinant construct was used to transform BL21-star competent cells, and protein expression was induced with 0.05 mM IPTG at 15°C overnight. Cells were harvested and lysed in bacterial lysis buffer (50 mM NaH~2~PO~4,~ 300 mM NaCl, and 10 mM imidazole, pH 8.0) supplemented with 1 mM PMSF (Sigma-Aldrich) and 0.4 mg/ml Lysozyme (Sigma-Aldrich), sonicated, and clarified by centrifugation at 4°C. Recombinant 6xHis-Mad1^1--493^ and 6xHis-BubR1^1--358^ were purified with Novex Dynabeads (Invitrogen) in bacterial lysis buffer.

To generate recombinant MBP-Megator fragments (aa 1--402; 403--800), PCR products harboring the coding sequences for fragments 1--402 and 403--800 of Megator were cloned between the EcoRI/PstI and KpnI/SbfI restriction sites of pMal-c2 (New England Biolabs) vector, respectively. A Megator fragment with the coding sequence for aa 1,187--1,655 was isolated through cDNA restriction with EcoRI and inserted at the EcoRI restriction site of pMal-c2. Megator^1,187--1,655/T4A^ and Megator^1,187--1,655/T4D^ were inserted into pMal-c2 vector through FastCloning ([@bib26]) using Phusion Polymerase (New England Biolabs). To generate pMal-c-Megator^1,187--1,655/T2D^ and pMal-c-Megator^1,187--1,655/T3D^, the codons corresponding to T1259 and T1390 or to T1259, T1338, and T1390 of pMal-c-Megator^1,187--1,655/WT^ were converted to codons for aspartate by several cycles of site-directed mutagenesis with primers harboring the desired mutations, using Phusion Polymerase (New England Biolabs). These constructs were used to transform TOP10 competent bacteria, and cells were selected for the incorporation of plasmids. Selected recombinant constructs were used to transform BL21-star competent cells, and protein expression was induced with 0.05 mM IPTG at 15°C overnight. Pellets of these cultures were lysed in column buffer (200 mM NaCl, 20 mM Tris-HCl, 1 mM EDTA, and 1 mM DTT, pH 7.4) supplemented with 1% Triton X-100 (Sigma-Aldrich), 1 mM PMSF (Sigma-Aldrich), and 0.4 mg/ml of lysozyme (Sigma-Aldrich), sonicated, and clarified by centrifugation at 4°C. Recombinant MBP-Megator fragments were purified with amylose magnetic beads (New England Biolabs) and eluted in Column Buffer supplemented with 10 mM Maltose. The purified recombinant proteins (eluted or bound to magnetic beads) were resolved by SDS-PAGE, and their relative amounts were determined after Coomassie blue staining. Similar amounts of protein were used in the subsequent assays.

In vitro kinase assays, MS analysis, and pull-down assays {#s17}
---------------------------------------------------------

For in vitro kinase assays, recombinant fragments of MBP-Megator were incubated with 0.05 µg HsMps1/TTK (SignalChem) in a total volume of 30 µl kinase reaction buffer (5 mM morpholino propane sulfonic acid, pH 7.2, 2.5 mM β-glycerol-phosphate, 5 mM MgCl~2~, 1 mM EGTA, 0.4 mM EDTA, 0.25 mM DTT, and 100 µM ATP supplemented with 1× phosphatase inhibitor cocktail 3 \[Roche\]). Reactions were performed at 30°C for 30 min and analyzed by autoradiography, subjected to MS analysis, or used in pull-down assays. For detection of ^32^P incorporation, the kinase reaction buffer was supplemented with 10 µCi \[γ-^32^P\]ATP (3,000 Ci/mmol and 10 mCi/ml), and the reaction was stopped by addition of Laemmli sample buffer, boiled for 5 min at 95°C, and resolved by SDS-PAGE. After drying at 80°C under vacuum, the gel was exposed to x-ray films (Fuji Medical). For identification of phosphorylated residues, the reaction was stopped by addition of 6 M urea and analyzed by liquid chromatography (LC) coupled with MS. Samples were digested with LysC/Trypsin and/or GluC and prepared for LC-MS/MS analysis as previously described ([@bib41]). Peptides (100 ng) were separated on an EASY-nLC 1000 HPLC system (Thermo Fisher Scientific) for 1 h from 5--60% acetonitrile with 0.1% formic acid and directly sprayed via a nano-electrospray source in a quadrupole Orbitrap mass spectrometer (Q Exactive; Thermo Fisher Scientific; [@bib33]). The Q Exactive was operated in data-dependent mode, acquiring one survey scan and subsequently 10 MS/MS scans ([@bib36]). Resulting raw files were processed with MaxQuant software (v1.5.2.18) using a reduced database containing only the proteins of interest and giving phosphorylation on serine, threonine, and tyrosine as variable modification ([@bib8]). A false discovery rate cutoff of 1% was applied at the peptide and protein levels and the phosphorylation site decoy fraction.

For pull-down assays, 6xHis-Mad1^1--493^ or 6xHis-BubR1^1--358^ bound to Novex Dynabeads (Invitrogen) was incubated with the MPB-Megator^1,187--1,655^ constructs in a final volume of 50 µl column buffer (250 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM DTT, 0.05% Tween20 \[Sigma-Aldrich\], 1× protease inhibitor cocktail (Roche), and 1× phosphatase inhibitor cocktail 3 \[Sigma-Aldrich\]) for 90 min at room temperature with agitation. The magnetic beads (with bound protein) were collected and washed three times with 500 µl column buffer, resuspended in Laemmli sample buffer and boiled at 95°C for 5 min. After removal of the magnetic beads, samples were resolved by SDS-PAGE and probed for proteins of interest through Western blotting. Quantification of MBP-Megator binding to 6xHis-Mad1^1--493^ was represented as the ratio between the chemiluminescence signal intensities of MBP-Megator and 6xHis-Mad1^1--493^. The values obtained for MBP-Megator^1,187--1,655/WT^ were set to 1.

siRNA-mediated depletion, drug treatments, and immunofluorescence analysis in human cultured cells {#s18}
--------------------------------------------------------------------------------------------------

HeLa and RPE1 cells were cultured in DMEM supplemented with 10% FBS (Invitrogen) in a 37°C incubator with 5% CO~2~. Depletion of Tpr was performed using a siRNA directed against the following target sequence: 5′-GCA​CAA​CAG​GAU​AAG​GUU​A-3′ (Sigma-Aldrich). siRNA transfection was performed using Lipofectamine RNAiMAX (Invitrogen) with 50 nM Tpr siRNA in final concentration for 48 h. Microtubule depolymerization in HeLa and RPE1 cells was induced by nocodazole (Sigma-Aldrich) at 3.3 µM for 3 or 6 h, respectively. To inhibit the proteasome, induce a metaphase arrest, and prevent mitotic exit due to a compromised SAC, cells were treated with 5 µM MG132 (EMD Millipore). For Mps1 inhibition, cells were treated with 1 µM reversine (Sigma-Aldrich) for 1 h before the addition of the other drugs (nocodazole and MG132).

For immunofluorescence assays, cells were fixed with either 4% PFA for 10 min or ice-cold ethanol for 3 min. In the case of the PFA fixation, cells were subsequently extracted in 0.3% Triton X-100 in 1× PBS for 10 min. After fixation and extraction, cells were blocked for 1 h with 10% FBS in PBS. Next, cells were incubated with primary antibodies at 4°C overnight and with the respective secondary antibodies for 1 h at room temperature. DNA was counterstained with DAPI (1 µg/ml; Sigma-Aldrich) before coverslips were mounted in 90% glycerol, 10% Tris, pH 8.5, and 0.5% *N*-propyl gallate on glass slides. Images were acquired on an AxioImager Z1 (63× plan-Apochromatic oil differential interference contrast objective lens, 1.4 NA; all from Carl Zeiss) equipped with a charge-coupled device camera (ORCA-R2; Hamamatsu Photonics) using Zen software (Carl Zeiss). 41 0.2-µm separated z-planes covering the entire mitotic cell were collected. Images were blind deconvolved using Autoquant X (Media Cybernetics), analyzed in ImageJ, and represented with a maximum-intensity projection of a deconvolved Z stack. For quantification measurements, all images compared were acquired using identical acquisition settings. Image analysis was performed using Imaris (Bitplane, Scientific Solutions). Briefly, individual KTs were automatically detected and represented as spots using centromere protein C (CenpC) staining. KT protein accumulation was measured by quantifying pixel gray levels for each channel within the selected spots. Background fluorescence was measured using ImageJ outside the KT region and subtracted. Fluorescent intensity measurements were normalized to the CenpC signals. The results are reported after normalization to relative fluorescence levels in control samples.

Antibodies {#s19}
----------

The following primary antibodies were used for immunofluorescence studies: rat anti-CID (Rat4) used at 1:250, rabbit anti-phosphorylated Thr676-Mps1 (T676; a gift from Geert Kops, Hubrecht Institute, Utrecht, Netherlands; [@bib18]) used at 1:2,000, chicken anti-GFP (ab13970; Abcam) used at 1:2,000 for S2 cells and 1:1,000 for neuroblasts, mouse anti-Megator (gift from Jørgen Johansen and Kristen Johansen, Iowa State University, Ames, IA; [@bib39]; RRID:AB_2721935) used at 1:20, rabbit anti-Mad1 (Rb1; [@bib7]) used at 1:2,500 for S2 cells and 1:1,000 for neuroblasts, mouse anti-C-Mad2 (Sigma-Aldrich) used at 1:50 for S2 cells, rat anti-Spc105 used at 1:250, guinea pig anti-Mps1 (Gp15; a gift from Scott Hawley, Stowers Institute for Medical Research, Kansas City, MO; RRID:AB_2567774) used at 1:250, rabbit anti-phosphorylated ser10-Histone H3 (p-H3; Millipore; RRID:AB_565299) used at 1:5,000, rat anti-Mad1 (Rat1) used at 1:1,000, rabbit anti-Nup107 (gift from Valérie Doye, Institut Jacques Monod CNRS-Université Paris Diderot, Paris, France; [@bib21]) used at 1:250, mouse anti-Mad1 (Merck Millipore) used at 1:500 in human cells, and human anti-CenpC (MBL) used at 1:500. The following primary antibodies were used for Western blotting studies: mouse anti--α-tubulin DM1A (Sigma-Aldrich; RRID:AB_477593) used at 1:10,000, rabbit anti-Cyclin B (gift from C. Lehner,  Institute for Molecular Life Sciences-University of Zurich, Zurich, Switzerland) used at 1:10,000, guinea pig anti-Mps1 (Gp15; a gift from Scott Hawley; RRID:AB_2567774) used at 1:5,000, mouse anti-Megator (gift from Jørgen Johansen and Kristen Johansen; [@bib39]; RRID:AB_2721935) used at 1:100, rabbit anti-Mad1 (Rb1; [@bib7]) used at 1:2,000, rabbit anti-Mad2 (Rb1223) used at 1:100, rabbit anti-BubR1 (Rb666; [@bib7]) used at 1:3,500, mouse anti-Cdc20 (mAb 20.B.9; a gift from S. Artavanis-Tsakonas, Harvard Medical School, Boston, MA; [@bib9]) used at 1:10, mouse anti-MBP (New England Biolabs; RRID:AB\_ 1559738) used at 1:5,000, and mouse anti-His-Tag (05-949; Millipore) used at 1:2,500.

Fly stocks {#s20}
----------

All fly stocks were obtained from Bloomington Stock Center unless stated otherwise. The mps1 mutant allele *mps1^G4422^* ([@bib3]) has been described and characterized before ([@bib7]; [@bib42]). *w^1118^* was used as WT control. Fly stocks harboring gEGFP-MPS1^WT^ and gEGFP-MPS1^325--630^ under control of Mps1 cis-regulatory region were kindly provided by Christian Lehner ([@bib2]).

Statistical analysis {#s21}
--------------------

All statistical analysis was performed with Prism V7.0f (GraphPad Software).

Online supplemental material {#s22}
----------------------------

[Fig. S1](#figS1){ref-type="fig"} shows that Mps1 promotes Mad1 dissociation from Megator. [Fig. S2](#figS2){ref-type="fig"} shows experiments with neuroblasts and cultured S2 cells demonstrating that Mps1-mediated dissociation of Mad1 from Megator is required for KT recruitment of Mad1. [Fig. S3](#figS3){ref-type="fig"} shows experiments supporting that Mps1-mediated dissociation of Mad1 from Tpr contributes for Mad1 KT localization in human cells. The videos show the mitotic progression of *w^1118^* ([Video 1](#video1){ref-type="fig"}), *InscGal4\>UAS-MegatorRNAi* ([Video 2](#video2){ref-type="fig"}), homozygous *mps1^G4422^* ([Video 3](#video3){ref-type="fig"}), or homozygous *mps1^G4422^*;*InscGal4\>UAS-MegatorRNAi* ([Video 4](#video4){ref-type="fig"}) neuroblasts.

Supplementary Material
======================

###### 

Click here for additional data file.
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